A biotechnology company focused on using cells derived from a patient's body for treatment of heart damage.
Industry: Health Care
First Day Return: -4.8%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 02/13/2007 |
Offer Price | $5.25 |
Price Range $6.00 - $8.00 | |
Offer Shares (mm) | 1.1 |
Deal Size ($mm) | $6 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/18/2008 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $6 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Sunrise, FL, United States |
Founded | 1999 |
Employees at IPO | 22 |
Website www.bioheartinc.com |